On December 28th, the 6th Guangdong-Hong Kong-Macao Greater Bay Area Biotechnology Innovation Enterprise Top 50 Awards Ceremony and Biotechnology Innovation Development Summit were grandly held in Nansha, Guangzhou. Shenzhen NewDEL Biotechnology Co., Ltd. (referred to as "NewDEL Biotech") stood out among many competitors with its outstanding innovative capabilities, growth rate, and development potential, and was awarded the "Rising Star Enterprise Award" in the Top 50 Innovative Enterprises in the Guangdong-Hong Kong-Macao Greater Bay Area Biotechnology.

The selection of the Top 50 Innovative Enterprises in the Guangdong-Hong Kong-Macao Greater Bay Area Biotechnology is organized by the Zhongchuang Industrial Research Institute and hosted by the Guangdong Medical Valley. Since the launch of the 6th edition of the Top 50 Innovative Enterprises in the Guangdong-Hong Kong-Macao Greater Bay Area Biotechnology, it has garnered widespread attention and coverage from various sectors. After more than four months of registration and on-site visits, the judges evaluated participating enterprises from three dimensions: leading technological applications and breakthroughs, market applications, and valuation and capital market recognition. They comprehensively assessed the technological innovation, business capabilities, and future development prospects of the participating enterprises. Finally, 50 enterprises were selected, including awards for Leading Enterprises, Pioneer Enterprises, Rising Star Enterprises, and Popularity Awards.

During the same period, a Biotechnology Innovation Development Summit was held, bringing together experts, scholars, investment heavyweights, and biotechnology companies from the Greater Bay Area. They collectively explored the latest trends in the biotechnology industry in the Greater Bay Area.

With the elevation of the strategic position of the Guangdong-Hong Kong-Macao Greater Bay Area and the advancement of the development stage of the biopharmaceutical industry, the innovation ecosystem in the Greater Bay Area is gradually improving, regional synergies are becoming more prominent, and the industrialization of technological achievements is accelerating. The selection of the top 50 innovative biotechnology enterprises in the Greater Bay Area provides a more active and efficient industry exchange platform for the development of biotechnology enterprises, facilitating the construction of the biotechnology industry ecosystem in the Greater Bay Area.

As a member of the biotechnology industry in the Greater Bay Area, NewDEL Biotech integrates DNA-encoded compound libraries with AI technology (DNA Encoded Library, SMART DEL) as its core technology for innovative drug development and technical services. We deeply understand that only through continuous innovation and research and development can we continue to move forward! In the future, NewDEL Biotech will continue to focus on the research and development innovation of new drug discovery and development, constantly innovate technology platforms, accelerate the upgrading of innovative drug research and development, and contribute to the vigorous development of biotechnology in the Greater Bay Area.